- Report
- February 2024
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 113 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 105 Pages
Europe
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2022
- 111 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Training
- 90 Minutes
Global
- Training
- January 2024
- 2 Days
Global
From €2639EUR$2,900USD£2,263GBP
- Training
- April 2025
- 3 Hours
Global
From €557EUR$613USD£478GBP
- Training
- November 2024
- 3 Hours
Global
From €558EUR$613USD£478GBP
- Training
- July 2024
- 3 Hours
Global
From €446EUR$490USD£382GBP
- Training
- February 2024
- 2 Days
Global
From €2639EUR$2,900USD£2,263GBP
- Training
- February 2024
- 90 Minutes
United States
From €633EUR$695USD£542GBP
- Training
- September 2023
- 2 Days
Global
From €2912EUR$3,200USD£2,497GBP
- Training
- August 2023
- 2 Days
Global
From €2639EUR$2,900USD£2,263GBP
- Training
- June 2023
- 1 Hour
Europe
From €781EUR$859USD£670GBP
- Webinar
- February 2023
- 360 Minutes
Global
From €542EUR$595USD£464GBP
From €1546EUR$1,699USD£1,326GBP
- Training
- March 2025
- 3 Hours
Global
From €557EUR$613USD£478GBP
- Training
- November 2024
- 1 Day
Global
From €557EUR$613USD£478GBP
- Training
- August 2024
- 90 Minutes
Global
- Training
- June 2024
- 60 Minutes
Global

The CGMP market is a subset of the pharmaceutical manufacturing industry, focusing on the production of drugs and other pharmaceutical products in accordance with Current Good Manufacturing Practices (CGMP). CGMPs are a set of regulations and guidelines issued by the US Food and Drug Administration (FDA) to ensure that pharmaceutical products are safe and effective. CGMPs cover all aspects of the manufacturing process, from raw materials to finished products, and include requirements for quality control, personnel training, and record keeping.
The CGMP market is highly competitive, with many large and small companies offering a variety of services. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Teva Pharmaceuticals, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more